Announce Date | 11/04/2024 |
EPS Normalized Actual | $-7.76441 (Miss by $-4.68441) |
EPS GAAP Actual | $-7.76441 (Miss by $-4.68441) |
Revenue Actual | $0.174733B |
Revenue Surprise | Beat by $174.733M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-3.58 |
EPS GAAP Estimate | $-3.58 |
Revenue Estimate | $0.1947B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | 0 | INF | 0 | 0 | 1 |
Dec 2024 | -13.39667 | -0.09 | -14.02 | -12.18 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2024 (Sep 2024) | -7.76 | -4.435 | 0.174733B | 7.14% | -13.17M |
FQ1 2020 (Mar 2020) | 0 | 0 | 0.176718B | 100% | 176.72M |
FQ2 2024 (Jun 2024) | -0.86 | -2.20259 | 0.188112B | 8.39% | -95.84M |
FQ1 2024 (Mar 2024) | -3.51 | 0.03 | 0.165407B | -0.92% | -23.79M |
FQ4 2023 (Dec 2023) | -1.35 | 3.67 | 0.166145B | -152.28% | -2.74M |
FQ3 2023 (Sep 2023) | -3.66 | -3.43 | 0.162258B | 12.29% | -43.95M |
FQ2 2023 (Jun 2023) | -5.51 | -5.51 | 0.172337B | 5.25% | 172.34M |
FQ1 2023 (Mar 2023) | -0.12 | -0.12 | 0.166932B | 100% | 166.93M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
-3.58
Consensus Revenue Estimates
0.1947B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | -3.26 | -- | -3.27204 | -3.24796 | 0 |
FQ3 2025 (Jul 2025) | -2.59 | -199.61 | -2.59957 | -2.58043 | 0 |
FQ2 2025 (Jun 2025) | -2.59 | 66.8 | -2.6009 | -2.5791 | 0 |
FQ1 2025 (Mar 2025) | -3.58 | 1.96 | -3.59506 | -3.56494 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.2B | -- | 0.2B | 0.2B | 0 |
FQ3 2025 (Jul 2025) | 0.2B | 12.98 | 0.2B | 0.2B | 0 |
FQ2 2025 (Jun 2025) | 0.2B | 6.32 | 0.2B | 0.2B | 0 |
FQ1 2025 (Mar 2025) | 0.19B | 15.05 | 0.19B | 0.2B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
3
Revenue # of Misses
5
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | -3.325 | -7.76 | -4.435 | 57.15% |
FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 1.34259 | -0.86 | -2.20259 | 256.12% |
FQ1 2024 (Mar 2024) | -3.54 | -3.51 | 0.03 | -0.85% |
FQ4 2023 (Dec 2023) | -5.02 | -1.35 | 3.67 | -271.85% |
FQ3 2023 (Sep 2023) | -0.23 | -3.66 | -3.43 | 93.72% |
FQ2 2023 (Jun 2023) | -5.51 | -5.51 | 100% | |
FQ1 2023 (Mar 2023) | -0.12 | -0.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2024 (Sep 2024) | $0.19B | $0.17B | $-13.17M | -7.54% |
FQ1 2020 (Mar 2020) | $0B | $0.18B | $176.72M | 100% |
FQ2 2024 (Jun 2024) | $0.28B | $0.19B | $-95.84M | -50.95% |
FQ1 2024 (Mar 2024) | $0.19B | $0.17B | $-23.79M | -14.38% |
FQ4 2023 (Dec 2023) | $0.17B | $0.17B | $-2.74M | -1.65% |
FQ3 2023 (Sep 2023) | $0.21B | $0.16B | $-43.95M | -27.09% |
FQ2 2023 (Jun 2023) | $0B | $0.17B | $172.34M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.17B | $166.93M | 100% |